GE HealthCare Technologies Inc. (GEHC)
Automate Your Wheel Strategy on GEHC
With Tiblio's Option Bot, you can configure your own wheel strategy including GEHC - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol GEHC
- Rev/Share 43.3217
- Book/Share 20.6083
- PB 3.509
- Debt/Equity 0.9997
- CurrentRatio 0.9765
- ROIC 0.0881
- MktCap 32299207900.0
- FreeCF/Share 3.0066
- PFCF 23.5074
- PE 14.7672
- Debt/Assets 0.2734
- DivYield 0.0018
- ROE 0.2587
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 4
- P/B Score 2
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | GEHC | UBS | Sell | Neutral | -- | $73 | May 5, 2025 |
| Upgrade | GEHC | Goldman | Neutral | Buy | $85 | $100 | March 11, 2025 |
| Upgrade | GEHC | Jefferies | Hold | Buy | $95 | $103 | Jan. 8, 2025 |
| Downgrade | GEHC | UBS | Neutral | Sell | $84 | $74 | Sept. 26, 2024 |
| Upgrade | GEHC | BTIG Research | Neutral | Buy | -- | $100 | Sept. 18, 2024 |
| Initiation | GEHC | JP Morgan | -- | Neutral | -- | $90 | Sept. 9, 2024 |
News
PharmaLogic Announces Appointment of Etienne Montagut as President and Chief Executive Officer
Published: June 02, 2025 by: PRNewsWire
Sentiment: Neutral
BOCA RATON, Fla. , June 2, 2025 /PRNewswire/ -- PharmaLogic Holdings Corp.
Read More
GEHC Stock May Rise Following the Launch of AI-Based CleaRecon DL
Published: May 16, 2025 by: Zacks Investment Research
Sentiment: Positive
GE HealthCare launches CleaRecon DL, an AI-powered 3D imaging tech that enhances cone-beam CT scans by reducing artifacts, improving clarity for better interventional care.
Read More
GE HealthCare Stock May Gain as FDA Approves Optison for Pediatric Use
Published: May 15, 2025 by: Zacks Investment Research
Sentiment: Positive
GEHC's Optison ultrasound agent receives FDA approval for pediatric use, improving echocardiogram clarity and advancing heart diagnostics for children with safer imaging.
Read More
GEHC Stock Surges as SIGNA Sprint MRI Redefines 1.5T Imaging Tech
Published: May 13, 2025 by: Zacks Investment Research
Sentiment: Positive
GE HealthCare unveils SIGNA Sprint MRI, a high-performance 1.5T system designed to boost diagnostic accuracy, accelerate imaging, and advance cardiac and cancer care.
Read More
ESTRO 2025 Congress: GE HealthCare to expand its radiation oncology portfolio and introduce new AI-enabled solutions
Published: May 02, 2025 by: Business Wire
Sentiment: Neutral
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced an intended expansion of its radiation oncology portfolio as well as the introduction of the new AI-enabled MR Contour DL™ at the European Society for Therapeutic Radiology and Oncology (ESTRO) 2025 Congress in Vienna, Austria. The company will also showcase its updated Intelligent Radiation Therapy (iRT), a software solution that standardizes complex workflows, helping to enable a shorter timeline from diagnosis to treatmen.
Read More
GE Healthcare sees tariffs costing $500 million in 2025, then much less next year
Published: April 30, 2025 by: Market Watch
Sentiment: Negative
GE Healthcare sees bilateral China tariffs accounting for most of the expected tariff cost, or roughly 75%.
Read More
GE HealthCare Q1 Earnings & Sales Beat Estimates, Net Margin Rises
Published: April 30, 2025 by: Zacks Investment Research
Sentiment: Positive
GEHC's first-quarter results reflect strength in the Imaging and Pharmaceutical Diagnostics segments. The bottom line improves on better pricing.
Read More
GE HealthCare Technologies Inc. (GEHC) Q1 2025 Earnings Call Transcript
Published: April 30, 2025 by: Seeking Alpha
Sentiment: Neutral
GE HealthCare Technologies Inc. (NASDAQ:GEHC ) Q1 2025 Earnings Conference Call April 30, 2025 8:30 AM ET Company Participants Carolynne Borders - Chief Investor Relations Officer Peter Arduini - President and Chief Executive Officer Jay Saccaro - Vice President and Chief Financial Officer Conference Call Participants Larry Biegelsen - Wells Fargo Jason Bednar - Piper Sandler Vijay Kumar - Evercore ISI Robbie Marcus - JPMorgan David Roman - Goldman Sachs Joanne Wuensch - Citi Craig Bijou - BofA Securities Anthony Petrone - Mizuho Financial Group Operator Good day, and thank you for standing by. Welcome to the GE HealthCare First …
Read More
Tariffs Weigh on GE HealthCare Outlook
Published: April 30, 2025 by: The Motley Fool
Sentiment: Negative
Here's our initial take on GE HealthCare's (GEHC 3.14%) first-quarter financial report.
Read More
GE HealthCare beats on earnings, slashes full year outlook due to tariffs
Published: April 30, 2025 by: CNBC
Sentiment: Neutral
GE HealthCare reported better-than-expected first-quarter results, beating analysts' estimates on top and bottom lines. The company slashed its annual forecast to account for the impact of President Donald Trump's tariff policy.
Read More
GE HealthCare (GEHC) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Published: April 30, 2025 by: Zacks Investment Research
Sentiment: Neutral
While the top- and bottom-line numbers for GE HealthCare (GEHC) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Read More
GE HealthCare Technologies (GEHC) Q1 Earnings and Revenues Top Estimates
Published: April 30, 2025 by: Zacks Investment Research
Sentiment: Positive
GE HealthCare Technologies (GEHC) came out with quarterly earnings of $1.01 per share, beating the Zacks Consensus Estimate of $0.91 per share. This compares to earnings of $0.90 per share a year ago.
Read More
GE HealthCare Results Top Estimates But Firm Cuts Profit Outlook Over Tariffs
Published: April 30, 2025 by: Investopedia
Sentiment: Negative
GE HealthCare Technologies (GEHC) on Wednesday posted first-quarter results that came in better than analysts had expected, but the former General Electric division lowered its full-year profit outlook because of tariffs.
Read More
GE HealthCare reports first quarter 2025 financial results
Published: April 30, 2025 by: Business Wire
Sentiment: Neutral
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today reported financial results for the first quarter ended March 31, 2025. GE HealthCare President and CEO Peter Arduini said, “First quarter results reflect strong execution as we start the year with robust revenue, orders and profit growth, which were driven by strength in the U.S. We remain focused on delivering on our precision care and growth acceleration strategies, underscored by the closing of our acquisition of Nihon Medi-Physics.
Read More
Here's Why You Should Hold the GEHC Stock in Your Portfolio for Now
Published: April 25, 2025 by: Zacks Investment Research
Sentiment: Positive
GE HealthCare's continued focus on innovations, acquisitions and partnerships raises optimism about the stock.
Read More
GE HealthCare to feature latest advancements in diagnostic accuracy and patient-centered breast care at SBI 2025 Breast Cancer Imaging Symposium
Published: April 24, 2025 by: Business Wire
Sentiment: Neutral
COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC), a global leader in breast health technology, will feature its latest advancements in diagnostic accuracy and patient-centered breast care during the 2025 Society of Breast Imaging Symposium in Colorado Springs, Co., April 24-27, 2025. This year's showcase will feature new innovations designed to improve breast cancer detection, streamline workflows, and enhance overall patient care. Mammography innovations streamline exam w.
Read More
GE HealthCare (GEHC) Surges 10.6%: Is This an Indication of Further Gains?
Published: April 10, 2025 by: Zacks Investment Research
Sentiment: Positive
GE HealthCare (GEHC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Read More
Why GE HealthCare Technologies Stock Fell Today
Published: April 03, 2025 by: The Motley Fool
Sentiment: Negative
Shares in GE HealthCare Technologies (GEHC -9.60%) were down 9.5% at 1 p.m. today. The decline follows the U.S.'s wide-scale implementation of tariffs.
Read More
GEHC Stock Gains Following Buyout Completion to Boost Its PDx Arm
Published: April 01, 2025 by: Zacks Investment Research
Sentiment: Positive
GE HealthCare aims to expand its existing footprint and offerings in Japan, as well as enhance patient access to next-generation radiopharmaceuticals via its latest acquisition.
Read More
GEHC Stock May Rise as Revolution Vibe CT Enhances Imaging Tech
Published: April 01, 2025 by: Zacks Investment Research
Sentiment: Positive
GE HealthCare introduces Revolution Vibe CT, a cutting-edge imaging system designed to enhance diagnostic precision, improve workflow efficiency, and expand accessibility.
Read More
GE HealthCare's Latest Product Launch to Boost Cardiology Care
Published: March 31, 2025 by: Zacks Investment Research
Sentiment: Positive
GEHC's latest commercial launch of Flyrcado and the grant of pass-through status by CMS aim to serve a wider patient pool across the United States.
Read More
GE HealthCare unveils Revolution™ Vibe CT system with Unlimited One-Beat Cardiac imaging and AI Solutions
Published: March 28, 2025 by: Business Wire
Sentiment: Neutral
CHICAGO--(BUSINESS WIRE)--At the American College of Cardiology 2025 meeting, GE HealthCare (Nasdaq: GEHC) will proudly introduce Revolution™ Vibe,i a new computed tomography (CT) system with Unlimited One-Beat Cardiac imaging to deliver consistent, high-quality images for patients, even in challenging cases like atrial fibrillation and heavily calcified coronaries. Combined with the company's impressive ECG-less Cardiac, TrueFidelity DL, SnapShot Freeze 2, and Effortless Workflow's AI-powered.
Read More
GE HealthCare announces cash dividend for first quarter of 2025
Published: March 27, 2025 by: Business Wire
Sentiment: Neutral
CHICAGO--(BUSINESS WIRE)--The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the first quarter of 2025 payable on May 15, 2025 to all shareholders of record as of April 25, 2025. About GE HealthCare Technologies Inc. GE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first AI-enabled soluti.
Read More
GEHC Stock Falls Despite New Launch to Boost Breast Cancer Diagnosis
Published: March 24, 2025 by: Zacks Investment Research
Sentiment: Positive
GE HealthCare aims to deliver optimal outcomes with its innovative, patient-friendly and efficient AI-driven technology via its latest product offering.
Read More
Here's Why You Should Hold GEHC Stock in Your Portfolio for Now
Published: March 24, 2025 by: Zacks Investment Research
Sentiment: Positive
GE HealthCare's continued focus on innovations, acquisitions and partnerships raises optimism about the stock.
Read More
3 Under-the-Radar Value AI Stocks With Market-Beating Potential
Published: March 20, 2025 by: The Motley Fool
Sentiment: Positive
These three stocks aren't conventionally seen as artificial intelligence (AI) stocks, yet AI is a critical part of the growth story of HVAC and building controls/software company Johnson Controls (JCI 1.58%), and electrical solutions company nVent Electric (NVT 2.45%). Meanwhile, integrating AI-enabled solutions is the key to long-term growth at GE HealthCare (GEHC 0.26%).
Read More
GE HealthCare expands invasive cardiology solutions portfolio with AltiX AI.i for elevated experience in catheterization lab and electrophysiology procedures
Published: March 17, 2025 by: Business Wire
Sentiment: Neutral
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the launch of the AltiX AI.i edition of Mac-Lab™, CardioLab™ and ComboLab™. The AltiX AI.i editions are designed to improve the user experience, elevating workflow in the cardiac catheterization (cath) lab and supporting even the most complex electrophysiology (EP) procedures. These latest editions offer new features that can streamline workflow and enhance interoperability, while upholding strong cybersecurity standards. Ca.
Read More
NVIDIA's AI Speeds Up MedTech's Digital Boom: 3 Stocks in Focus
Published: March 12, 2025 by: Zacks Investment Research
Sentiment: Positive
RMD, GEHC and MDT are expected to thrive as NVIDIA and other AI leaders' MedTech ventures accelerate digital adoption within the space.
Read More
Goldman Sachs Gains Confidence In Market Rebound, Upgrades GE Healthcare Amid China Recovery Hopes
Published: March 11, 2025 by: Benzinga
Sentiment: Positive
Last week, U.S. President Donald Trump vowed to impose a 25% tariff on imported goods from Mexico and Canada and to double tariffs on those from China to 20%.
Read More
GEHC Stock May Gain as Genesis Portfolio Expands Cloud Offerings
Published: March 11, 2025 by: Zacks Investment Research
Sentiment: Positive
GE HealthCare unveils Genesis, a cloud-based imaging portfolio designed to enhance healthcare efficiency, streamline data access, and drive digital transformation.
Read More
About GE HealthCare Technologies Inc. (GEHC)
- IPO Date 2022-12-15
- Website https://www.gehealthcare.com
- Industry Medical - Healthcare Information Services
- CEO Mr. Peter J. Arduini
- Employees 53000